Scarica l'app Stockscreener
4.79
0.00%
0.00
Precedente Chiudi:
$4.79
Aprire:
$4.77
Volume 24 ore:
838.36K
Relative Volume:
1.09
Capitalizzazione di mercato:
$288.18M
Reddito:
-
Utile/perdita netta:
$-44.80M
Rapporto P/E:
-6.3867
EPS:
-0.75
Flusso di cassa netto:
$-30.67M
1 W Prestazione:
-1.64%
1M Prestazione:
-6.63%
6M Prestazione:
+78.40%
1 anno Prestazione:
-9.45%
Intervallo 1D:
$4.675
$4.81
Intervallo di 1 settimana:
$4.67
$5.04
Portata 52W:
$1.14
$7.20
Aldeyra Therapeutics Inc Stock (ALDX) Company Profile
Nome
Aldeyra Therapeutics Inc
Settore
Industria
Telefono
781-761-4904
Indirizzo
131 HARTWELL AVENUE, LEXINGTON, MA
Confronta ALDX con altri titoli
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
ALDX
Aldeyra Therapeutics Inc
|
4.79 | 288.18M | 0 | -44.80M | -30.67M | -0.75 |
|
VRTX
Vertex Pharmaceuticals Inc
|
444.64 | 110.88B | 11.74B | 3.68B | 3.34B | 14.19 |
|
REGN
Regeneron Pharmaceuticals Inc
|
726.21 | 72.79B | 14.25B | 4.58B | 3.88B | 41.77 |
|
ARGX
Argen X Se Adr
|
890.11 | 54.76B | 3.06B | 1.28B | 447.35M | 19.67 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
404.46 | 54.85B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
INSM
Insmed Inc
|
189.85 | 41.41B | 447.02M | -1.18B | -906.14M | -6.1812 |
Aldeyra Therapeutics Inc Stock (ALDX) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2024-04-03 | Aggiornamento | Oppenheimer | Perform → Outperform |
| 2024-04-02 | Ripresa | H.C. Wainwright | Buy |
| 2022-04-27 | Ripresa | H.C. Wainwright | Buy |
| 2021-02-08 | Iniziato | H.C. Wainwright | Buy |
| 2020-12-16 | Iniziato | Berenberg | Buy |
| 2020-10-30 | Iniziato | Jefferies | Buy |
| 2020-10-16 | Iniziato | BTIG Research | Buy |
| 2020-09-22 | Iniziato | Alliance Global Partners | Buy |
| 2020-05-12 | Iniziato | Oppenheimer | Outperform |
| 2018-12-04 | Iniziato | Citigroup | Buy |
| 2018-09-26 | Reiterato | Cantor Fitzgerald | Overweight |
| 2018-09-13 | Iniziato | Janney | Buy |
| 2018-01-26 | Iniziato | Seaport Global Securities | Buy |
| 2016-09-26 | Iniziato | H.C. Wainwright | Buy |
| 2016-07-01 | Iniziato | Stifel | Buy |
| 2015-07-01 | Iniziato | Canaccord Genuity | Buy |
| 2015-03-25 | Iniziato | Chardan Capital Markets | Buy |
| 2015-03-20 | Reiterato | H.C. Wainwright | Buy |
| 2014-11-18 | Iniziato | H.C. Wainwright | Buy |
| 2014-06-19 | Iniziato | Aegis Capital | Buy |
Mostra tutto
Aldeyra Therapeutics Inc Borsa (ALDX) Ultime notizie
Adversity is less terrifying than hope: Aldeyra Therapeutics Inc (ALDX) - Setenews
Aldeyra Therapeutics, Inc.'s (NASDAQ:ALDX) recent 10% pullback adds to one-year year losses, institutional owners may take drastic measures - Yahoo Finance
Winners Losers: Will Aldeyra Therapeutics Inc stock maintain momentum in 2025 - BỘ NỘI VỤ
It makes sense and dollars to buy Aldeyra Therapeutics Inc (ALDX) stock - Setenews
Aldeyra Therapeutics Inc (137.DU) Stock Price, News, Quote & History - Yahoo! Finance Canada
Is Aldeyra Therapeutics Inc. stock oversold or undervaluedCEO Change & Smart Allocation Stock Reports - Newser
Will Aldeyra Therapeutics Inc. stock maintain momentum in 2025Bull Run & Free Technical Confirmation Trade Alerts - BỘ NỘI VỤ
Can Aldeyra Therapeutics Inc. stock deliver surprise earnings beatChart Signals & Long-Term Capital Growth Strategies - moha.gov.vn
Will Aldeyra Therapeutics Inc. stock benefit from infrastructure spendingJuly 2025 Analyst Calls & Fast Entry and Exit Trade Plans - moha.gov.vn
Does Aldeyra Therapeutics (NASDAQ:ALDX) Have A Healthy Balance Sheet? - simplywall.st
Why retail investors favor Aldeyra Therapeutics Inc. stock2025 Short Interest & Free Growth Oriented Trading Recommendations - newser.com
Aldeyra Therapeutics Inc Stock Analysis and ForecastContrarian Investment Ideas & Small Investment Trading Tips - earlytimes.in
The time has not yet come to remove your chips from the table: Aldeyra Therapeutics Inc (ALDX) - Setenews
Dry Eye Disease Market Size was ~USD 3.76 Billion in 2023 and expected to Grow by 2034, Analysed DelveInsight - Barchart.com
HC Wainwright Has Bullish Estimate for ALDX FY2025 Earnings - Defense World
What sentiment indicators say about Aldeyra Therapeutics Inc. stockJuly 2025 News Drivers & AI Based Buy/Sell Signal Reports - newser.com
Intraday pattern recognizer results for Aldeyra Therapeutics Inc.July 2025 Closing Moves & Daily Profit Maximizing Trade Tips - newser.com
Aldeyra Therapeutics Inc. stock daily chart insightsTrend Reversal & AI Forecast Swing Trade Picks - newser.com
Understanding Aldeyra Therapeutics Inc.’s price movement - newser.com
Live market analysis of Aldeyra Therapeutics Inc.CEO Change & Short-Term High Return Ideas - newser.com
How Aldeyra Therapeutics Inc. stock performs in weak economyGap Down & Weekly Market Pulse Alerts - newser.com
Why Aldeyra Therapeutics Inc. stock is in analyst buy zonePortfolio Update Summary & High Conviction Buy Zone Alerts - newser.com
Can a trend reversal in Aldeyra Therapeutics Inc. lead to recoveryPortfolio Risk Report & Fast Exit and Entry Trade Guides - newser.com
Applying Wyckoff theory to Aldeyra Therapeutics Inc. stock2025 Market Trends & Daily Growth Stock Investment Tips - newser.com
Brokers Offer Predictions for ALDX Q1 Earnings - Defense World
What candlestick patterns are forming on Aldeyra Therapeutics Inc.Market Growth Report & Risk Managed Trade Strategies - newser.com
Aldeyra Therapeutics Inc.’s volatility index tracking explainedMarket Performance Recap & Real-Time Volume Surge Alerts - newser.com
Aldeyra Therapeutics, Inc. (ALDX) Discusses Expansion of RASP Platform Into CNS Diseases and Update on Reproxalap for Dry EyeSlideshow (NASDAQ:ALDX) 2025-11-16 - Seeking Alpha
Sentiment analysis tools applied to Aldeyra Therapeutics Inc.July 2025 Recap & Weekly Market Pulse Alerts - newser.com
Smart tools for monitoring Aldeyra Therapeutics Inc.’s price actionWeekly Trading Summary & AI Forecast Swing Trade Picks - newser.com
What to expect from Aldeyra Therapeutics Inc. in the next 30 daysTrade Ideas & Weekly Top Gainers Trade List - newser.com
Aldeyra Therapeutics Inc Azioni (ALDX) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
0.45%
0.12%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):